Is Milestone Pharmaceuticals Inc. (MIST) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 40.7% / 30% | 51.8% / 30% | 1.8% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 40.7% / 33% | 51.8% / 33% | 1.8% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 72.6% / 33% | 92.3% / 33% | 3.2% / 33% | N/A | ✗ NOT HALAL |
| S&P | 40.7% / 33% | 51.8% / 33% | 1.8% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 72.6% / 33% | 92.3% / 33% | 3.2% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 100.0% | |
| Operating Margin | -1116.2% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -229.7% | |
| Return on Assets (ROA) | -41.1% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$29M |
| Free Cash Flow | -$29M |
| Total Debt | $55M |
| Debt-to-Equity | 139.8 |
| Current Ratio | 8.0 |
| Total Assets | $75M |
Price & Trading
| Last Close | $1.15 |
| 50-Day MA | $1.72 |
| 200-Day MA | $1.89 |
| Avg Volume | 2.3M |
| Beta | 0.5 |
|
52-Week Range
$0.62
| |
About Milestone Pharmaceuticals Inc. (MIST)
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Milestone Pharmaceuticals Inc. (MIST) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Milestone Pharmaceuticals Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Milestone Pharmaceuticals Inc.'s debt ratio?
Milestone Pharmaceuticals Inc.'s debt ratio is 40.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 72.6%.
What are Milestone Pharmaceuticals Inc.'s key financial metrics?
Milestone Pharmaceuticals Inc. has a market capitalization of $122M. Return on equity stands at -229.7%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.